Actos News
Most Popular Actos Story
GSK shakes up R&D
Like so many other big drug developers, GlaxoSmithKline has announced that it will be shaking up its R&D operations. The goal? To create new drugs faster and cheaper. Speaking to the Financial Read more...
Latest Headlines
- November 18, 2011
- August 21, 2009
- April 10, 2008
- March 28, 2008
- December 12, 2007
- October 29, 2007
- July 30, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
